LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 53.04 | 27.76 | 4268 | 5365 | 0.7954 | 0.9406 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 53.04 | 27.76 | 2177 | 5365 | 0.4057 | 0.7760 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 53.04 | 27.76 | 4920 | 5365 | 0.9169 | 0.9773 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 54.74 | 27.76 | 4494 | 5606 | 0.8016 | 0.9431 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 54.74 | 27.76 | 4518 | 5606 | 0.8058 | 0.9444 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 54.74 | 27.76 | 2340 | 5606 | 0.4174 | 0.7843 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 54.74 | 27.76 | 5186 | 5606 | 0.9250 | 0.9797 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 56.45 | 27.76 | 4702 | 5745 | 0.8184 | 0.9486 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 56.45 | 27.76 | 4723 | 5745 | 0.8220 | 0.9497 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 56.45 | 27.76 | 2471 | 5745 | 0.4301 | 0.7923 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 56.45 | 27.76 | 5287 | 5745 | 0.9202 | 0.9785 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.15 | 27.76 | 4872 | 5906 | 0.8248 | 0.9508 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.15 | 27.76 | 4894 | 5906 | 0.8286 | 0.9520 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.15 | 27.76 | 2677 | 5906 | 0.4532 | 0.8055 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.15 | 27.76 | 5619 | 5906 | 0.9513 | 0.9871 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 59.85 | 27.76 | 5099 | 6062 | 0.8411 | 0.9559 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 59.85 | 27.76 | 5120 | 6062 | 0.8445 | 0.9570 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 59.85 | 27.76 | 2782 | 6062 | 0.4589 | 0.8092 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 59.85 | 27.76 | 5838 | 6062 | 0.9630 | 0.9903 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 61.56 | 27.76 | 5312 | 6217 | 0.8544 | 0.9601 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 61.56 | 27.76 | 5332 | 6217 | 0.8576 | 0.9610 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 61.56 | 27.76 | 2875 | 6217 | 0.4624 | 0.8119 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 61.56 | 27.76 | 6078 | 6217 | 0.9776 | 0.9942 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 63.26 | 27.76 | 5468 | 6465 | 0.8457 | 0.9578 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 63.26 | 27.76 | 5491 | 6465 | 0.8493 | 0.9589 | MN20160318_Q01 | H11 |